# FDA Inspection 1102420 - Andre Lacroix, MD - August 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/andre-lacroix-md/3553aad9-1055-460e-8717-f96cf70b6e41
Source feed: FDA_Inspections

> FDA Inspection 1102420 for Andre Lacroix, MD on August 30, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102420
- Company Name: Andre Lacroix, MD
- Inspection Date: 2019-08-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/andre-lacroix-md/c99638ec-855b-447b-b3e2-ce63664df652

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c